Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients
Abstract Esophageal squamous cell carcinoma (ESCC) has a dismal prognosis because of atypical early symptoms and heterogeneous therapeutic responses. 5-methylcytosine (m5C) modification plays an important role in the onset and development of many tumors and is widespread in long non-coding RNA (lncR...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-09-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-41495-6 |
| _version_ | 1797452992331382784 |
|---|---|
| author | Yuan Ma Yuchen Sun Xu Zhao Jing Li Xing Fu Tuotuo Gong Xiaozhi Zhang |
| author_facet | Yuan Ma Yuchen Sun Xu Zhao Jing Li Xing Fu Tuotuo Gong Xiaozhi Zhang |
| author_sort | Yuan Ma |
| collection | DOAJ |
| description | Abstract Esophageal squamous cell carcinoma (ESCC) has a dismal prognosis because of atypical early symptoms and heterogeneous therapeutic responses. 5-methylcytosine (m5C) modification plays an important role in the onset and development of many tumors and is widespread in long non-coding RNA (lncRNA) transcripts. However, the functions of m5C and lncRNAs in ESCC have not been completely elucidated. Herein, this study aimed to explore the role of m5C-related lncRNAs in ESCC. The RNA-seq transcriptome profiles and clinical information were downloaded from the TCGA-ESCC database. Pearson analysis was used to identify m5C-related lncRNAs. Then we established the m5C-related lncRNAs prognostic signature (m5C-LPS) using univariate Cox and least absolute shrinkage and selection operator (LASSO) regression analysis. Then, the prognostic value of m5C-LPS was evaluated internally and externally using the TCGA-ESCC and GSE53622 databases through multiple methods. We also detected the expression of these lncRNAs in ESCC cell lines and patient tissues. Fluorescence in situ hybridization (FISH) was used to detect the prognostic value of specific lncRNA. In addition, clinical parameters, immune status, genomic variants, oncogenic pathways, enrichment pathways, and therapeutic response features associated with m5C-LPS were explored using bioinformatics methods. We constructed and validated a prognostic signature based on 9 m5C-related lncRNAs (AC002091.2, AC009275.1, CAHM, LINC02057.1, AC0006329.1, AC037459.3, AC064807.1, ATP2B1-AS1, and UBAC2-AS1). The quantitative real-time polymerase chain reaction (qRT-PCR) revealed that most lncRNAs were upregulated in ESCC cell lines and patient tissues. And AC002091.2 was validated to have significant prognostic value in ESCC patients. A composite nomogram was generated to facilitate clinical practice by integrating this signature with the N stage. Besides, patients in the low-risk group were characterized by good clinical outcomes, favorable immune status, and low oncogenic alteration. Function enrichment analysis indicated that the risk score was associated with mRNA splicing, ncRNA processing, and DNA damage repair response. At the same time, we found significant differences in the responses to chemoradiotherapy between the two groups, proving the value of m5C-LPS in treatment decision-making in ESCC. This study established a novel prognostic signature based on 9 m5C-related lncRNAs, which is a promising biomarker for predicting clinical outcomes and therapeutic response in ESCC. |
| first_indexed | 2024-03-09T15:16:25Z |
| format | Article |
| id | doaj.art-42b74a2bb3a247b4bfae188a7b4692d7 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-03-09T15:16:25Z |
| publishDate | 2023-09-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-42b74a2bb3a247b4bfae188a7b4692d72023-11-26T13:03:51ZengNature PortfolioScientific Reports2045-23222023-09-0113111510.1038/s41598-023-41495-6Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patientsYuan Ma0Yuchen Sun1Xu Zhao2Jing Li3Xing Fu4Tuotuo Gong5Xiaozhi Zhang6Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityAbstract Esophageal squamous cell carcinoma (ESCC) has a dismal prognosis because of atypical early symptoms and heterogeneous therapeutic responses. 5-methylcytosine (m5C) modification plays an important role in the onset and development of many tumors and is widespread in long non-coding RNA (lncRNA) transcripts. However, the functions of m5C and lncRNAs in ESCC have not been completely elucidated. Herein, this study aimed to explore the role of m5C-related lncRNAs in ESCC. The RNA-seq transcriptome profiles and clinical information were downloaded from the TCGA-ESCC database. Pearson analysis was used to identify m5C-related lncRNAs. Then we established the m5C-related lncRNAs prognostic signature (m5C-LPS) using univariate Cox and least absolute shrinkage and selection operator (LASSO) regression analysis. Then, the prognostic value of m5C-LPS was evaluated internally and externally using the TCGA-ESCC and GSE53622 databases through multiple methods. We also detected the expression of these lncRNAs in ESCC cell lines and patient tissues. Fluorescence in situ hybridization (FISH) was used to detect the prognostic value of specific lncRNA. In addition, clinical parameters, immune status, genomic variants, oncogenic pathways, enrichment pathways, and therapeutic response features associated with m5C-LPS were explored using bioinformatics methods. We constructed and validated a prognostic signature based on 9 m5C-related lncRNAs (AC002091.2, AC009275.1, CAHM, LINC02057.1, AC0006329.1, AC037459.3, AC064807.1, ATP2B1-AS1, and UBAC2-AS1). The quantitative real-time polymerase chain reaction (qRT-PCR) revealed that most lncRNAs were upregulated in ESCC cell lines and patient tissues. And AC002091.2 was validated to have significant prognostic value in ESCC patients. A composite nomogram was generated to facilitate clinical practice by integrating this signature with the N stage. Besides, patients in the low-risk group were characterized by good clinical outcomes, favorable immune status, and low oncogenic alteration. Function enrichment analysis indicated that the risk score was associated with mRNA splicing, ncRNA processing, and DNA damage repair response. At the same time, we found significant differences in the responses to chemoradiotherapy between the two groups, proving the value of m5C-LPS in treatment decision-making in ESCC. This study established a novel prognostic signature based on 9 m5C-related lncRNAs, which is a promising biomarker for predicting clinical outcomes and therapeutic response in ESCC.https://doi.org/10.1038/s41598-023-41495-6 |
| spellingShingle | Yuan Ma Yuchen Sun Xu Zhao Jing Li Xing Fu Tuotuo Gong Xiaozhi Zhang Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients Scientific Reports |
| title | Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients |
| title_full | Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients |
| title_fullStr | Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients |
| title_full_unstemmed | Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients |
| title_short | Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients |
| title_sort | identification of m5c related lncrnas signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients |
| url | https://doi.org/10.1038/s41598-023-41495-6 |
| work_keys_str_mv | AT yuanma identificationofm5crelatedlncrnassignaturetopredictprognosisandtherapeuticresponsesinesophagealsquamouscellcarcinomapatients AT yuchensun identificationofm5crelatedlncrnassignaturetopredictprognosisandtherapeuticresponsesinesophagealsquamouscellcarcinomapatients AT xuzhao identificationofm5crelatedlncrnassignaturetopredictprognosisandtherapeuticresponsesinesophagealsquamouscellcarcinomapatients AT jingli identificationofm5crelatedlncrnassignaturetopredictprognosisandtherapeuticresponsesinesophagealsquamouscellcarcinomapatients AT xingfu identificationofm5crelatedlncrnassignaturetopredictprognosisandtherapeuticresponsesinesophagealsquamouscellcarcinomapatients AT tuotuogong identificationofm5crelatedlncrnassignaturetopredictprognosisandtherapeuticresponsesinesophagealsquamouscellcarcinomapatients AT xiaozhizhang identificationofm5crelatedlncrnassignaturetopredictprognosisandtherapeuticresponsesinesophagealsquamouscellcarcinomapatients |